Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures FTSE (0.02%), DAX (0.24%), CAC40 (0.07%)

Oct 29 ,2025

  • Synopsis

    • European equity markets are set for a negative open amidst mostly higher Asia equities on Wednesday to send MSCI Asia Pac-ex Japan index to a fresh record high. More gains for South Korea and Taiwan with technology names also giving the Nikkei 225 an advantage over the Topix. Mainland China markets reversing yesterday's losses, India also slightly higher. Southeast Asia mixed. Australia dragged lower on higher-than-expected inflation. Hong Kong closed for a holiday. US futures mixed with S&P 500 higher but Nasdaq slightly lower.

    • General election held in the Netherlands (Reuters). In the UK, PMQs at 12noon GMT follows MPs question on Wales, whilst committee topics include COP30 at 10:00GMT, UK's future relationship with the US at 10:30, Budget 2025 at 14:15 and UK refineries and the role of oil and gas at 15:00. In Germany, Chancellor Merz deliver the opening speech in the kick-off event for the "High-Tech Agenda Germany".

    • Elsewhere, Annual conf of BaFin' Insurance Supervision Authority, OMFIF event at 10:00GMT 'The FCA's stablecoin and crypto custody roadmap', FT hosts Energy Transition Summit (through Thu) and DIW publishes its latest economic barometer.

    • A busy morning for earnings kicked off with reports from the DACHs region, UBS Group (UBSG.SW), Logitech (LOGN.SW), Temenos (TEMN.SW), Mercedes-Benz Group (MBG.GR), Adidas (ADS.GR), Deutsche Bank (DBK.GR) and BASF (BAS.GR). In France, DBV Technologies (DBV.FP) and Bic (BB.FP) are out with Q3 whilst in the Nordics, Equinor (EQNR.NO), Telenor (TEL.NO), Alm. Brand (ALMB.DC) and SKF (SKF.B.SS) released reports. In Southern Europe, Banco Santander (SAN.SM), Moncler (MONC.IM) and Ferrovial (FER.SM) are amongst companies updating on Q3.

    • Also due to release earnings/updates today are GSK (GSK.LN), Aston Martin Lagonda Global Holdings (AML.LN), Glencore (GLEN.LN), Next (NXT.LN),

  • Politics/Macro/World News

    • Reeves vows to 'defy' gloomy economic forecasts - BBC

    • Dutch vote in elections in test of European populism's reach - Reuters

  • Top company news

    • Earnings/updates

      • Benelux:

        • ASM.NA (ASM International) -- reports Q3 adjusted net income €206.2M vs FactSet €179.2M [7 est, €160.6-189.6M]

        • AED.BB (Aedifica) -- reports 9M EPRA EPS €3.91 vs year-ago €3.75

        • MELE.BB (Melexis) -- reports Q3 EPS €0.68 vs FactSet €0.70 [3 est, €0.65-0.74]

        • CRBN.NA (Corbion) -- reports Q3 EBIT €27.9M vs year-ago €28.5M; narrows FY organic volume/mix guidance

        • ALLFG.NA (Allfunds Group) -- reports Q3 revenue €156.1M vs FactSet €154.0M [8 est, €149.2-164.9M]

      • DACHs:

        • UBSG.SW (UBS Group) -- reports Q3 EPS $0.76 vs consensus $0.39

        • LOGN.SW (Logitech International) -- reports Q2 EPS $1.45 ex-items vs StreetAccount $1.20

        • MBG.GR (Mercedes-Benz Group) -- reports Q3 EPS €1.22 vs FactSet €1.32 [2 est, €1.20-1.43]

        • DBK.GR (Deutsche Bank) -- reports Q3 net income attributable €1.56B vs consensus €1.34B; on track to deliver 2025 financial targets

        • BAS.GR (BASF) -- reports Q3 adj EPS €0.52 vs consensus €0.34; cuts FY25 adj EBITDA outlook to reflect contribution of discontinued coatings businesses after the transaction with Carlyle

        • ADS.GR (Adidas) -- reports final Q3 results: EPS €2.57 vs FactSet €2.66 [13 est, €1.86-3.10]

        • TEMN.SW (Temenos) -- reports Q3 EPS $0.93 non IFRS vs consensus $0.77; raises FY25 guidance; reconfirms FY28 targets

        • STMN.SW (Straumann Holding) -- reports Q3 revenue CHF602.2M vs consensus CHF599.0M; confirms its FY25 outlook

        • OMV.AV (OMV) -- reports Q3 Clean CCS Net Income attributable €594M vs consensus €471M

        • RDC.GR (Redcare Pharmacy) -- reports final Q3 earnings: adj. EBITDA €17.1M vs FactSet €16.0M [3 est, €14.5-18M]; reaffirms FY guidance

        • AAD.GR (Amadeus FiRe) -- reports 9M EPS (€0.09) vs year-ago €4.79

        • DWS.GR (DWS Group) -- reports Q3 net income €219M vs consensus €210M; FY25 outlook unchanged

        • DRW3.GR (Drägerwerk AG & Co.) -- confirms prelim Q3 earnings and FY25 outlook as per 15-Oct update

      • France:

        • DBV.FP (DBV Technologies) -- reports Q3 GAAP EPS ($0.24) vs year-ago ($0.32)

        • BB.FP (Bic) -- reports preliminary Q3 revenue €519M vs FactSet €515M [1 est]

        • EMEIS.FP (Emeis SA) -- reports 9M revenue €4.39B, +5% vs year-ago €4.17B; confirms FY25 outlook and medium-term targets

        • SOP.FP (Sopra Steria Group) -- reports Q3 revenue €1.32B vs FactSet €1.34B [1 est]

        • VETO.FP (Vetoquinol) -- reports Q3 revenue €126.5M vs FactSet €133.5M [3 est, €132-135.8M]

        • MMT.FP (M6-Metropole) -- reports Q3 EBITA €37.5M vs FactSet €36.3M

        • PIG.FP (Haulotte Group) -- reports Q3 revenue €121M, (17%) vs year-ago €145M

        • SCHP.FP (Seche Environnement) -- reports Q3 revenue €277.3M vs FactSet €289.0M [2 est, €286-292M]

      • Nordics:

        • EQNR.NO (Equinor) -- reports Q3 EPS $0.37 ex-items vs consensus $0.58

        • TEL.NO (Telenor) -- reports Q3 net income NOK3.03B vs consensus NOK3.44B

        • ALMB.DC (Alm. Brand) -- reports Q3 EPS DKK0.20 vs FactSet DKK0.28 [4 est, DKK0.25-0.30]

        • BNOR.NO (BlueNord) -- reports Q3 net income $12.9M vs year-ago $11.0M

        • IRLAB.A.SS (IRLAB Therapeutics) -- reports Q3 EPS (SEK0.26) vs year-ago (SEK0.61)

        • NOD.NO (Nordic Semiconductor) -- reports Q3 Adjusted EBITDA $18.3M vs FactSet $23.3M [12 est, $20-26M]

        • MING.NO (SpareBank 1 SMN) -- reports Q3 net income NOK1.17B vs FactSet NOK991.6M [7 est, NOK925-1.05B]

        • ACR.NO (Axactor) -- reports Q3 EPS €0.03 vs FactSet €0.03 [2 est, €0.03-0.03]

        • NEL.NO (NEL ASA) -- reports Q3 net income (NOK85M) vs FactSet (NOK124.3M) [4 est, (NOK148)-(104M)]

        • PHO.NO PhotoCure) -- reports Q3 net income NOK4.0M vs FactSet (NOK2M) [2 est, (NOK2)-(2M)]

        • SWEC.B.SS (Sweco) -- reports Q3 EPS SEK1.17 vs FactSet SEK1.21 [5 est, SEK1.14-1.40]

        • EPRO.B.SS (Electrolux Professional) -- reports Q3 EPS SEK0.14 vs FactSet SEK0.41 [2 est, SEK0.06-0.75]

        • SKF.B.SS (SKF) -- reports Q3 EPS SEK3.96 ex-items vs FactSet SEK3.10 [11 est, SEK1.56-4.10]

        • SVED.B.SS (Svedbergs Group) -- reports Q3 EPS SEK0.92 vs FactSet SEK0.84 [3 est, SEK0.80-0.88]

        • POSTI.FH (Posti Group) -- reports Q3 EPS €0.13 vs year-ago €0.30

        • JYSK.DC (Jyske Bank) -- reports final Q3: EPS DKK23.20 vs FactSet DKK22.24 [6 est, DKK19.61-23.15

        • SHOT.SS (Scandic Hotels Group) -- reports Q3 EPS SEK3.00 vs FactSet SEK3.08 [3 est, SEK2.89-3.20]

      • Southern Europe:

        • SAN.SM (Banco Santander) -- reports Q3 underlying net income attributable €3.50B vs FactSet €3.36B [11 est, €3.14-3.51B]; confident will achieve 2025 targets

        • MONC.IM (Moncler) -- reports Q3 revenue €615.6M vs consensus €603.8M

        • FER.SM (Ferrovial) -- reports 9M revenue €6.91B, +4% vs year-ago €6.64B

        • PRS.SM (Promotora de Informaciones) -- reports Q3 net income (€20M) vs year-ago (€13M)

        • ENC.SM (ENCE Energia y Celulosa) -- reports Q3 net income (€16.2M) vs FactSet (€15M) [3 est, (€19.6)-(6.1M)]

        • VID.SM (Vidrala) -- reports 9M EPS €4.93 vs year-ago €5.05; reaffirms FY guidance

    • M&A

      • ENG.SM (Enagas) -- completes acquisition of 51% of the share capital of Axent Infraestructuras de Telecomunicaciones, S.A

      • PSG.GR (PharmaSGP Holding) -- increases adequate cash compensation from €29.33 to €30.64 per share under squeeze-out

    • Healthcare

      • RLF.SW (RELIEF THERAPEUTICS Holding) -- announces positive results from pivotal bioequivalence study of RLF-OD032

      • NOVN.SW (Novartis) -- CORRECTION: Novartis expects rapid Rhapsido US uptake beginning early 2026

      • ROG.SW (Roche Holding) -- receives CE mark for novel automated high-throughput Elecsys Dengue Ag test to diagnose dengue

      • UCB.BB (UCB) -- to unveil new data for RYSTIGGO and ZILBRYSQ for gMG at the 2025 AANEM Annual Meeting and MGFA Scientific Session

      • STMN.SW (Straumann Holding) -- Straumann Group transforms its orthodontics business through new strategic partnerships with Smartee; financial details remain confidential

      • DBV.FP (DBV Technologies) -- SEC filing: 10-Q

      • XBRANE.SS (Xbrane Biopharma) -- responds to questions following delay in FDA approval for Lucamzi

    • Other

      • MBG.GR (Mercedes-Benz Group) -- to commence share repurchase program; shares worth up to €2B are to be repurchased over period of up to 12 months

      • SOP.FP (Sopra Steria Group) -- notes search for a new CEO has been launched by the board and its Nomination, Governance, Ethics & Corporate Responsibility Committee

      • STLAM.IM (Stellantis) -- announces robotaxi collaboration with NVIDIA, Uber and Foxconn

      • LDO.IM (Leonardo) -- launches accelerated bookbuilding process addressed to institutional investors of c. 2.6M shares in Avio SpA

      • NOKIA.FH (Nokia) -- Transcript Intelligence: Nokia Business Update Call

      • BAS.GR (BASF SE) -- board resolves on share buyback program of up to €1.5B to begin in Nov-25 and conclude in Jun-26

      • LLOY.LN (Lloyds Banking Group) -- files offering of $1B fixed rate reset additional Tier 1 perpetual subordinated contingent convertible securities - 424B2

      • P911.GR (Porsche) -- Street Takeaways - Porsche Quarterly Statement January-September 2025

      • AMUN.FP (Amundi) -- UniCredit wants to reduce level of client money it invests through Amundi to almost zero in less than two years - Bloomberg (28-Oct, 14:35 CET)

      • PHNX.LN (Phoenix Group Holdings) -- Phoenix Group in talks to raise over £1B from private capital firms for expanding pension-risk transfer business - FT

      • Nokia soars on Nvidia investment while quantum computing names lower on NVQLink reveal in intraday themes (28-Oct)

  • Key rating changes

    • Downgrades

      • FER.SM (Ferrovial) -- neutral from outperform at Oddo

  • Data

    • Nikkei +2.17% to 51307.65

    • Hang Seng +0.00% to 26346.14

    • Shanghai Composite +0.59% to 4011.78

    • S&P futures +17.0 vs prior close of 6925.8

    • €-$ (0.0022) or (0.19%) to 1.1629

    • $-¥ +0.03 or +0.02% to 152.14

    • €-¥ (0.32) or (0.18%) to 176.92

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE